Brigatinib is a small-molecule compound used as an active pharmaceutical ingredient. It is designed to inhibit specific receptor tyrosine kinases, including anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1197953-54-0
5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine
active pharmaceutical ingredient
6-Methylthioguanine
metabolite of thioguanine drug
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride
pharmaceutical intermediate
(3S)-1-azabicyclo[2.2.2]octan-3-amine dihydrochloride
active pharmaceutical ingredient
Z944
T-type calcium channel blocker
5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
AILRADAXUVEEIR-UHFFFAOYSA-N
CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC